🌐 Entity
Acoramidis
Chemical compound
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Biotechnology (1)
- Pharmaceutical Development (1)
- Investment Analysis (1)
🏷️ Keywords
Barclays (1) · BridgeBio (1) · Attruby (1) · Overweight rating (1) · Biotech stocks (1) · Clinical trials (1) · Pharmaceutical (1) · Investment recommendation (1)
📖 Key Information
Acoramidis, sold under the brand name Attruby, is a medication used for the treatment of cardiomyopathy. It is a near-complete (>90%) transthyretin stabilizer, developed to mimic the protective properties of the naturally occurring T119M mutation, to treat transthyretin amyloid cardiomyopathy. It is taken by mouth.
📰 Related News (1)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Acoramidis:
-
Barclays · 1 shared articles